About Kesar Pharma
Kesar Pharma is a Healthcare company based in Ahmedabad (India) founded in 1994, and was acquired by Vaishali Pharma in February 2025. Pharmaceutical finished formulations including tablets and capsules are manufactured. It operates on a Reseller / Distribution and Private Labeling / White Label model. The company has 47 employees. Its Indian entity Kesar Pharma Limited reported revenue of ₹20.63 Cr. Kesar Pharma offers products and services including Tablets, Capsules, Liquid Orals, and Injectables. Its focus areas include Pharmaceuticals and Generic Drugs.
Company details
Kesar Pharma is involved in the development and manufacturing of pharmaceutical formulations including tablets, capsules, liquid orals, ointments, injectables, and sustained-release preparations. Operations are conducted through state-of-the-art facilities in Gujarat, India, adhering to international standards such as WHO GMP and CGMP. The company serves both domestic and global markets, with a presence in 30 international markets. Contract manufacturing and private labeling are offered to multinational and leading Indian pharmaceutical brands. Research and development for new molecules and APIs are also undertaken to meet global healthcare needs.
- Headquarters Ahmedabad, India
- Employees 47
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kesarpharma.com
- Acquired by Vaishali Pharma (Feb 2025)
- Legal Name Kesar Pharma Pvt. Ltd.
- Date of Incorporation 18 Oct, 2011
- Jurisdiction Gandhinagar, Gujarat, India
- Annual Revenue₹20.63 Cr
FY 2025 · -26% YoY
- Net Profit₹21.5 Lakh
FY 2025 · 1% margin
- EBITDA₹1.82 Cr
FY 2025 · 9% margin
- Investors
- Employee Count47
- Acquired byVaishali Pharma
(Feb 2025)
Associated legal entities of Kesar Pharma
Kesar Pharma operates through Kesar Pharma Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kesar Pharma Limited CIN U24239GJ2011PLC067520 | Active | 18 Oct 2011 | Gandhinagar, Gujarat | ₹20.6 Cr | 47 | 5 | View details |
Products & Services of Kesar Pharma
Kesar Pharma offers a comprehensive portfolio of products and services, including Tablets, Capsules, Liquid Orals, and Injectables.
Tablets are manufactured for various therapeutic uses globally.
Capsules are produced for diverse medical treatment needs.
Liquid orals are formulated for easy patient consumption.
Injectables are developed for critical healthcare treatment purposes.
Investors in Kesar Pharma
Kesar Pharma has secured backing from 1 investor. Prominent investors backing the company include Vaishali Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finished formulations, APIs, and intermediates are manufactured. | 1989 | vaishalipharma.com | Mumbai, India |
Investor details for Kesar Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Kesar Pharma Limited (Kesar Pharma)
Kesar Pharma Limited is the primary company behind Kesar Pharma. The board of Kesar Pharma Limited currently have 5 directors; the longest-serving is Prakash Ambalal Patel, appointed in 2011. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prakash Ambalal Patel DIN 02239510 | Director | 18 Oct 2011 | 15 yrs | Kesar Pharma Limited |
| Kalpesh Navnitlal Shah DIN 02727578 | Director | 01 May 2014 | 12 yrs 5 mo | Kesar Pharma Limited |
| Parth Hemant Parikh DIN 08542493 | Director | 06 Sep 2019 | 7 yrs 1 mo | Kesar Pharma Limited |
| Kevin Atul Vasani DIN 10264026 | Director | 15 Apr 2025 | 1 yr 6 mo | Kesar Pharma Limited |
| Rumit Bharatbhai Gopani DIN 11076476 | Director | 15 Apr 2025 | 1 yr 6 mo | Kesar Pharma Limited |
Financials of Kesar Pharma
Figures of Kesar Pharma Limited, the primary company behind Kesar Pharma, for FY 2025. Revenue was ₹20.63 Cr (-26% year on year). Net profit was ₹21.5 Lakh (1% margin). EBITDA was ₹1.82 Cr (9% margin). Revenue has grown at a compounded annual rate of -25% over three years and -9% over five years.
- ₹20.63 CrRevenue · FY 2025 · -26% YoY
- ₹21.5 LakhNet profit · 1% margin
- ₹1.82 CrEBITDA · 9% margin
- ₹4.32 CrPaid-up capital
- 47Employees (provident fund records)
- -25%Revenue CAGR, 3 years
- -9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kesar Pharma Limited are on its company page.
Detailed financial statements for Kesar Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Kesar Pharma
2 dated milestones of Kesar Pharma across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Kesar Pharma is founded.
- Exit Acquired by Vaishali Pharma.
Web traffic of Kesar Pharma
Websites that share an audience with Kesar Pharma (kesarpharma.com).
Websites whose visitors overlap most with Kesar Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| senorespharma.com | 100% | 14.7K | #1,809,604 | View details | |
farbefirma.org | farbefirma.org | 95% | #2,275,733 | – | |
| helenzpharma.com | 94% | #10,048,496 | View details | ||
aliyanpharma.com | aliyanpharma.com | 93% | #6,956,014 | – | |
nafdac.gov.ng | nafdac.gov.ng | 88% | #352,013 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Kesar Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Kesar Pharma (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kesar Pharma
Kesar Pharma was founded in 1994.
Kesar Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Kesar Pharma has 47 employees.
The primary company behind Kesar Pharma, Kesar Pharma Limited, reported revenue of ₹20.63 Cr for FY 2025, down 26% year on year.
Kesar Pharma is involved in the development and manufacturing of pharmaceutical formulations including tablets, capsules, liquid orals, ointments, injectables, and sustained-release preparations. Operations are conducted through state-of-the-art facilities in Gujarat, India, adhering to international standards such as WHO GMP and CGMP. The company serves both domestic and global markets, with a presence in 30 international markets. Contract manufacturing and private labeling are offered to multinational and leading Indian pharmaceutical brands. Research and development for new molecules and APIs are also undertaken to meet global healthcare needs.
Kesar Pharma offers Tablets, Capsules, Liquid Orals, and Injectables.
Kesar Pharma has 1 investor. Key investors include Vaishali Pharma.
Kesar Pharma operates through Kesar Pharma Limited.
Yes. Kesar Pharma was acquired by Vaishali Pharma in February 2025.
The legal entities of Kesar Pharma currently have 5 directors, including Parth Hemant Parikh, Kevin Atul Vasani, Prakash Ambalal Patel and others.